{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:17:48Z","timestamp":1794565068110,"version":"4.9.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015311","name":"Novartis Institutes for BioMedical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ebiom.2025.105748","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T19:33:19Z","timestamp":1747078399000},"page":"105748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-1646","authenticated-orcid":false,"given":"Beryl B.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-1941","authenticated-orcid":false,"given":"Page R.","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0972-0908","authenticated-orcid":false,"given":"Mark N.","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Moesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyas","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Trauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Maratos-Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Voznesensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Splawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh V.","family":"Nimonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"DiPetrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"LaSala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan M.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Huet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdeep K.","family":"Sahambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Knee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Cebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Lehrer-Graiwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3714-6084","authenticated-orcid":false,"given":"Rebecca A.","family":"Juliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9936-5816","authenticated-orcid":false,"given":"Ethan J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105748_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcvm.2020.00088","article-title":"The evolving understanding and approach to residual cardiovascular risk management","volume":"7","author":"Dhindsa","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ebiom.2025.105748_bib2","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/eurheartj\/ehad337","article-title":"Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study","volume":"44","author":"Bj\u00f6rnson","year":"2023","journal-title":"Eur Hear J"},{"key":"10.1016\/j.ebiom.2025.105748_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ebiom.2025.105748_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Hear J"},{"key":"10.1016\/j.ebiom.2025.105748_bib5","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1161\/ATVBAHA.123.319297","article-title":"Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a mendelian randomization study","volume":"43","author":"Navarese","year":"2023","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.ebiom.2025.105748_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MOL.0000000000000921","article-title":"Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events","volume":"35","author":"Raggi","year":"2024","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ebiom.2025.105748_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97918","article-title":"Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis","volume":"3","author":"Aryal","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2025.105748_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1253\/circj.CJ-20-1037","article-title":"New trends in dyslipidemia treatment","volume":"85","author":"Jang","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.ebiom.2025.105748_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100150","article-title":"Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism","volume":"62","author":"Kersten","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2025.105748_bib10","article-title":"Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk","volume":"4","author":"Landfors","year":"2024","journal-title":"Eur Hear J Open"},{"key":"10.1016\/j.ebiom.2025.105748_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001547","article-title":"Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation","volume":"20","author":"Richardson","year":"2022","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ebiom.2025.105748_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117558","article-title":"Impact of loss-of-function in angiopoietin-like 4 on the human phenome","volume":"393","author":"Gagnon","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ebiom.2025.105748_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105748_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2010.11.002","article-title":"Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages","volume":"12","author":"Lichtenstein","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.105748_bib15","doi-asserted-by":"crossref","first-page":"11766","DOI":"10.1073\/pnas.0705041104","article-title":"Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice","volume":"104","author":"Desai","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2025.105748_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1194\/jlr.M074278","article-title":"Feeding Angptl4 \u2212\/\u2212 mice trans fat promotes foam cell formation in mesenteric lymph nodes without leading to ascites[S]","volume":"58","author":"Oteng","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2025.105748_bib17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"New Engl J Medicine"},{"key":"10.1016\/j.ebiom.2025.105748_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/protein\/gzq002","article-title":"An improved yeast transformation method for the generation of very large human antibody libraries","volume":"23","author":"Benatuil","year":"2010","journal-title":"Protein Eng, Des Sel"},{"key":"10.1016\/j.ebiom.2025.105748_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nprot.2006.94","article-title":"Isolating and engineering human antibodies using yeast surface display","volume":"1","author":"Chao","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2025.105748_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1194\/jlr.D700044-JLR200","article-title":"Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis","volume":"49","author":"Yee","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2025.105748_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0192623318761348","article-title":"Use of severity grades to characterize histopathologic changes","volume":"46","author":"Schafer","year":"2018","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ebiom.2025.105748_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ab.2004.12.032","article-title":"Characterization of high-affinity antibodies by electrochemiluminescence-based equilibrium titration","volume":"339","author":"Haenel","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ebiom.2025.105748_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ab.2017.08.002","article-title":"Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions","volume":"536","author":"Kamat","year":"2017","journal-title":"Anal Biochem"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:19:06Z","timestamp":1762618746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":23,"alternative-id":["S2352396425001926"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105748","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105748"}}